The results from high-resolution nanoparticle flow cytometry revealed that treatment with aT-sEVs significantly increased the secretion level of PD-L1+ sEVs in human oral cancer, melanoma, breast cancer and lung cancer cell lines (Fig. 4h and Supplementary Fig. 5f–h). Here, CD274 is linked to lip and oral cavity carcinoma.